- JP-listed companies
- ASKA pharmaceutical Co., Ltd.
- Income statement
ASKA pharmaceutical Co., Ltd.【JP:E00929】Income statement
Market cap
P/E ratio
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | |
| Revenue | 40,637 | 40,963 | 39,501 | 42,907 | 43,215 | 48,527 | 48,944 | 46,706 | 52,542 |
| Cost of revenue | - | - | - | 25,717 | 26,072 | 29,614 | 30,059 | 27,814 | 28,525 |
| Gross profit | - | - | - | 17,189 | 17,143 | 18,913 | 18,884 | 18,891 | 24,016 |
| Gross margin (%) | - | - | - | ||||||
| Operating expenses | - | - | - | 15,767 | 15,978 | 17,119 | 16,060 | 17,107 | 22,509 |
| Operating income | - | - | - | 1,425 | 1,166 | 1,793 | 2,824 | 1,782 | 1,507 |
| Income before tax | 1,224 | 1,336 | 1,031 | 1,722 | 1,522 | 2,002 | 3,073 | 1,980 | 1,715 |
| Provision for income taxes | - | - | - | 530 | 746 | 356 | 674 | 138 | 252 |
| Net income | - | - | - | 1,193 | 701 | 2,944 | 2,388 | 1,744 | 649 |
| Earnings per share | 0.27 | 40.27 | 17.85 | 42.89 | 25.15 | 105.39 | 84.8 | 61.81 | 22.96 |
| Dividend per share | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 17 |